- Home
- EDD vs CADL Comparison
EDD vs CADL Comparison
Compare EDD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDD
- CADL
- Stock Information
- Founded
- EDD 2007
- CADL 1999
- Country
- EDD United States
- CADL United States
- Employees
- EDD N/A
- CADL N/A
- Industry
- EDD Finance Companies
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EDD Finance
- CADL Health Care
- Exchange
- EDD Nasdaq
- CADL Nasdaq
- Market Cap
- EDD 307.8M
- CADL 306.4M
- IPO Year
- EDD N/A
- CADL 2021
- Fundamental
- Price
- EDD $4.79
- CADL $8.75
- Analyst Decision
- EDD
- CADL Strong Buy
- Analyst Count
- EDD 0
- CADL 4
- Target Price
- EDD N/A
- CADL $21.00
- AVG Volume (30 Days)
- EDD 254.3K
- CADL 1.4M
- Earning Date
- EDD 01-01-0001
- CADL 03-13-2025
- Dividend Yield
- EDD 7.52%
- CADL N/A
- EPS Growth
- EDD N/A
- CADL N/A
- EPS
- EDD N/A
- CADL N/A
- Revenue
- EDD N/A
- CADL N/A
- Revenue This Year
- EDD N/A
- CADL N/A
- Revenue Next Year
- EDD N/A
- CADL N/A
- P/E Ratio
- EDD N/A
- CADL N/A
- Revenue Growth
- EDD N/A
- CADL N/A
- 52 Week Low
- EDD $4.22
- CADL $1.34
- 52 Week High
- EDD $4.95
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EDD 54.11
- CADL 52.73
- Support Level
- EDD $4.71
- CADL $7.65
- Resistance Level
- EDD $4.81
- CADL $8.31
- Average True Range (ATR)
- EDD 0.05
- CADL 0.92
- MACD
- EDD -0.01
- CADL -0.10
- Stochastic Oscillator
- EDD 53.57
- CADL 33.33
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.